MHRA Updates
The latest guidances, approvals, and safety alerts from MHRA, curated by automated regulatory intelligence.
Rectifies a carton labeling typographical error where hydrochlorothiazide strength was printed as “12.
Publishes an MHRA list of Field Safety Notices issued between 02 and 06 October 2026, indicating active post-market safety communications affecting regulated…
Class 4 defect notification informs that Sandoz has reported errors in the Co-amoxiclav SmPC dosing table for 250/62.5 mg/5 mL oral suspension.
Initiates a Class 3 medicines recall for specific batches of Tropicamide 1% eye drops in single-dose containers due to incorrect expiry dates on the labels.
Lists MHRA Field Safety Notices issued between 26 and 30 October 2026, signalling active post-market safety communications across affected products.
Provides a roundup of the latest MHRA safety advice for medicines and medical device users, which may signal emerging safety concerns and updated risk…
Initiates a Class 2 medicines recall by Accord-UK Ltd for a single batch of lercanidipine hydrochloride 10 mg film-coated tablets due to a packaging mix-up…
Initiates a precautionary Class 2 medicines recall for specified batches of Mynzepli 40 mg/mL solution for injection in pre-filled syringes by Advanz Pharma…
Field Safety Notices (FSNs) issued between 19 and 23 October 2026 are listed, which may require manufacturers and supply-chain partners to review…
Initiates a Class 2 medicines recall related to Xeal Pharma clopidogrel oral suspension and oral solution products because testing indicates the finished…
Publishes an MHRA register entry listing Field Safety Notices issued during 5 to 9 October 2026.
Publishes a list of MHRA Field Safety Notices issued between 12 and 16 October 2026, highlighting active post-market safety communications that may require…
Identifies specified lots of Nova Biomedical StatStrip ketone test strips with quality-control (QC) failures, prompting a recall due to potential unreliability…
Publication listing MHRA Field Safety Notices issued between 27 and 31 January 2025.
Recommends considering delayed administration of concurrent echinocandins (e.g., caspofungin) during CRRT using new polyacrylonitrile (PAN)-based filter…
Initiates a Class 2 recall of Pedmarqsi 80 mg/mL solution for infusion for specified batches due to a risk of particulate matter detected during routine…
Field Safety Notices for October 2026 indicates a planned set of MHRA safety communications that may trigger updated risk controls, handling instructions, or…
Field Safety Notices (FSNs) for 8–12 June 2026 are listed, indicating an ongoing series of safety communications that may require manufacturers, distributors…
Field Safety Notices are being issued/updated over 21–25 September 2026, with a list published for the period 28 September–2 October 2026.
Initiates a Class 3 medicines recall by Norgine Limited for specific batches of MOVICOL Plain 13.7g powder for oral solution as a precautionary response to…